Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study.
Saved in:
| Title: | Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study. |
|---|---|
| Authors: | Kolinger, Guilherme Domingues1 (AUTHOR) g.kolinger@life-mi.com, Sotolongo-Grau, Oscar2 (AUTHOR), Roé-Vellvé, Núria1 (AUTHOR), Tartari, Juan Pablo2 (AUTHOR), Sanabria, Ángela2,3 (AUTHOR), Pérez-Martínez, Esther1 (AUTHOR), Koglin, Norman1 (AUTHOR), Stephens, Andrew W.1 (AUTHOR), Alegret, Montserrat2,3 (AUTHOR), Tárraga, Lluís2,3 (AUTHOR), Gurruchaga, Miren Jone2 (AUTHOR), Ruiz, Agustín2,3,4 (AUTHOR), Boada, Mercè2,3 (AUTHOR), Bullich, Santiago1 (AUTHOR), Marquié, Marta2,3 (AUTHOR), on behalf of the FACEHBI study group (AUTHOR), Aguilera, N. (AUTHOR), Alarcón-Martín, E. (AUTHOR), Alegret, M. (AUTHOR), Alllué, J. A. (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Aug2025, Vol. 52 Issue 10, p3578-3590. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-025-07270-7 |
